The Analyst Landscape: 4 Takes On Ikena Oncology
The Analyst Landscape: 4 Takes On Ikena Oncology
分析师格局：Ikena Oncology 的 4 种看法
4 analysts have expressed a variety of opinions on Ikena Oncology (NASDAQ:IKNA) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，有4位分析师对Ikena Oncology（纳斯达克股票代码：IKNA）表达了各种观点，从看涨到看跌，提出了各种各样的观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.25, a high estimate of $11.00, and a low estimate of $8.00. Observing a downward trend, the current average is 6.82% lower than the prior average price target of $11.00.
分析师12个月目标股价的见解已经公布，平均目标股价为10.25美元，最高估计为11.00美元，低估值为8.00美元。从下降趋势来看，当前的平均价格比之前的平均目标价11.00美元低6.82％。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析师评级：深度探索
In examining...
在研...
登录免费看全文
登录/注册